Jazz Pharmaceuticals JAZZ Stock Issued During Period, Value, Stock Options Exercised
Stock Issued During Period, Value, Stock Options Exercised at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's stock issued during period, value, stock options exercised.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's stock issued during period, value, stock options exercised?
- Jazz Pharmaceuticals (JAZZ) reported stock issued during period, value, stock options exercised of $32.9M in Q1 2026.
- How has Jazz Pharmaceuticals's stock issued during period, value, stock options exercised changed year-over-year?
- Jazz Pharmaceuticals's stock issued during period, value, stock options exercised increased by 186.1% year-over-year, from $11.5M to $32.9M.
- What is the long-term trend for Jazz Pharmaceuticals's stock issued during period, value, stock options exercised?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's stock issued during period, value, stock options exercised has grown at a -7.2% compound annual growth rate (CAGR), from $119.06M to $88.47M.
- What does stock issued during period, value, stock options exercised mean?
- Cash received by the company when employees exercise their stock options.
- How do you interpret stock issued during period, value, stock options exercised?
- Higher values indicate significant employee participation in equity programs, which can be a sign of long-term alignment but also results in share dilution.
- How does stock issued during period, value, stock options exercised compare across companies?
- Standard line item in the financing section of the cash flow statement for public companies with equity incentive plans.